HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,000 | +100.0% | 19 | +18.8% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -90.0% | 16 | -82.6% | 0.00% | -100.0% |
Q3 2018 | $10,000 | +11.1% | 92 | -14.0% | 0.00% | 0.0% |
Q2 2018 | $9,000 | +28.6% | 107 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | +600.0% | 107 | +328.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | – | 25 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |